GlassScriptPhysician profile
Joshua Bentley
NPI 1740523869
$5,657.45
in general payments reported to CMS, 2019-2025
22 companies · $640 in 2025
The $640 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,166 · 2020: $312 · 2021: $108 · 2022: $46.26 · 2023: $247 · 2024: $139 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,025.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microvention, INC. | $3,776.18 | 2019 | |
| Stryker Corporation | $433.19 | 2019-2025 | Surpass Evolve, Target, Trevo |
| Medtronic, INC. | $252.78 | 2025 | Pipeline |
| Portola Pharmaceuticals, LLC | $154.75 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $137.18 | 2023-2024 | Andexxa |
| Abbott Laboratories | $112.41 | 2020-2023 | Proclaim |
| Medtronic USA, INC. | $92.71 | 2019 | |
| Intrinsic Therapeutics | $91.49 | 2025 | Barricaid Acd (Annular Closure Device) |
| Nevro Corp. | $85.91 | 2019-2020 | |
| Providence Medical Technology, INC. | $80.26 | 2025 | |
| Depuy Synthes Sales INC. | $78.17 | 2021-2022 | |
| Nuvasive, INC. | $75.77 | 2019 | |
| Boston Scientific Corporation | $69.08 | 2025 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Imperative Care, INC | $56.87 | 2023 | Zoom 88-T Large Distal Platform |
| Chiesi USA, INC. | $43.68 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossur Americas, INC. | $42.36 | 2025 | |
| Contego Medical, INC | $23.19 | 2025 | |
| Integra Lifesciences Corporation | $17.78 | 2019 | |
| Scientia Vascular | $16.52 | 2023 | |
| Kls-Martin L.P. | $8.98 | 2021 | |
| Orthofix Medical, INC. | $8.19 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Bentley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.